Akcea Therapeutics, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-07-13: Reporting owner CROOKE STANLEY T; Form 3; Security No securities are beneficially owned.; Transaction Holding.
- 2017-07-13: Reporting owner PARSHALL B LYNNE; Form 3; Security No securities are beneficially owned.; Transaction Holding.
- 2017-07-13: Reporting owner HOUGEN ELIZABETH L; Form 3; Security No securities are beneficially owned.; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-07-13 holding as of filing | CROOKE STANLEY T Director | 3 | No securities are beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2017-07-13 | |
| 2017-07-13 holding as of filing | PARSHALL B LYNNE Director | 3 | No securities are beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2017-07-13 | |
| 2017-07-13 holding as of filing | HOUGEN ELIZABETH L Officer (Chief Financial Officer) | 3 | No securities are beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2017-07-13 |